Optics express · 2025
High-contrast and stable operation of a plasmonically-enhanced GSST-based phase-change memory cell using plasmonic chain modes for photonic memory applications.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Biswas Chinmoy, Ferdous Jannatul, Zeal Zahin Ikbal, Hoque A K M Hasibul, Tsui Ying Yin, Islam Md Zahurul
Аннотация
PURPOSE: IgAN is a common primary glomerular disease, and age may affect its clinical manifestations and progression. However, age-related differences in elderly IgAN, especially the role of podocyte senescence and the cGAS-STING pathway in elderly IgAN patients, remain incompletely understood.
PATIENTS AND METHODS: This retrospective study analyzed 1012 renal biopsy‑confirmed IgAN patients from January 2014 to January 2024, categorized into elderly (≥60 years, n=119) and younger (18-60 years, n=893)) groups after exclusion. Clinical, laboratory, and pathological data were collected. Kaplan-Meier survival analysis and Cox proportional hazard models were used to evaluate prognostic factors. Expression of the cGAS-STING pathway in renal tissues was detected to explore its association with podocyte injury. SASP in serum was detected by ELISA and qPCR.
RESULTS: Compared with the young IgAN group, the elderly IgAN group had higher levels of 24-hour urinary protein, urea and creatinine; lower hemoglobin and albumin; more severe tubular atrophy/interstitial fibrosis (T1/2 lesions, 47.1% vs. 23.9%); lower IgA immunofluorescence intensity; and more severe podocyte fusion. Kaplan-Meier analysis showed poorer renal outcomes in the elderly IgAN group (P<0.05). Multivariate Cox regression identified podocyte fusion (>50%) as an independent prognostic factor in the elderly IgAN group (HR=5.72, P=0.011) but not in the young IgAN group.The cGAS-STING pathway is highly expressed in the podocyte of IgAN, especially in the elderly, SASPs in serum, such as IL-6, IL-10, were also highly expressed in the elderly IgAN group, indicating that its activation is related to severe podocyte fusion, elevated proteinuria, and impaired renal function.
CONCLUSION: Elderly IgAN patients exhibit distinct clinicopathological features dominated by chronic lesions and podocyte injury. Severe podocyte fusion (>50%) is a critical independent prognostic factor for this population. The cGAS-STING pathway may mediate age-related podocyte senescence and injury, representing a potential therapeutic target for elderly IgAN patients.
PATIENTS AND METHODS: This retrospective study analyzed 1012 renal biopsy‑confirmed IgAN patients from January 2014 to January 2024, categorized into elderly (≥60 years, n=119) and younger (18-60 years, n=893)) groups after exclusion. Clinical, laboratory, and pathological data were collected. Kaplan-Meier survival analysis and Cox proportional hazard models were used to evaluate prognostic factors. Expression of the cGAS-STING pathway in renal tissues was detected to explore its association with podocyte injury. SASP in serum was detected by ELISA and qPCR.
RESULTS: Compared with the young IgAN group, the elderly IgAN group had higher levels of 24-hour urinary protein, urea and creatinine; lower hemoglobin and albumin; more severe tubular atrophy/interstitial fibrosis (T1/2 lesions, 47.1% vs. 23.9%); lower IgA immunofluorescence intensity; and more severe podocyte fusion. Kaplan-Meier analysis showed poorer renal outcomes in the elderly IgAN group (P<0.05). Multivariate Cox regression identified podocyte fusion (>50%) as an independent prognostic factor in the elderly IgAN group (HR=5.72, P=0.011) but not in the young IgAN group.The cGAS-STING pathway is highly expressed in the podocyte of IgAN, especially in the elderly, SASPs in serum, such as IL-6, IL-10, were also highly expressed in the elderly IgAN group, indicating that its activation is related to severe podocyte fusion, elevated proteinuria, and impaired renal function.
CONCLUSION: Elderly IgAN patients exhibit distinct clinicopathological features dominated by chronic lesions and podocyte injury. Severe podocyte fusion (>50%) is a critical independent prognostic factor for this population. The cGAS-STING pathway may mediate age-related podocyte senescence and injury, representing a potential therapeutic target for elderly IgAN patients.